Health and Fitness Health and Fitness
Fri, October 30, 2009
Thu, October 29, 2009
Wed, October 28, 2009

Gamma Pharmaceuticals Announces Agreement With J&A Lazier Racing LLC


Published on 2009-10-28 05:40:25 - Market Wire
  Print publication without navigation


LAS VEGAS, NV--(Marketwire - October 28, 2009) - Gamma Pharmaceuticals Inc. (the "Company") (PINKSHEETS: [ GMPM ]) announced it has signed a Product Brokerage Agreement with J&A Lazier Racing LLC of California. Mr. Lazier, an accomplished Indy Car Driver, will benefit from Gamma's Professional Grade vitamin supplements, nutritional and energy products to ensure peak athletic performance during the demanding Indy Car season. Gamma will make the products developed for the Indy Car race conditions available to consumers worldwide through Gamma's global distribution platform.

Peter Cunningham, Gamma's CEO, stated, "We are thrilled to be in business with such an elite global athlete and personality. Gamma will be Mr. Lazier's off-track pit crew. The objective is to keep Mr. Lazier in peak performance condition for the Indy Car season."

The Product Brokerage Agreement supports Gamma's entry into the world of Indy Car Racing. Indy Car Racing is the premier motor sport in the US with a substantial domestic and global following. The sport fits Gamma's global identity and up-market brand profile. The Indianapolis 500 is the largest single day sporting event in the world, attracting nearly 150 million television viewers and approximately 500,000 spectators. Gamma has built a full promotional and marketing program designed to attract motor sports fans to Gamma's branded products.

About Gamma Pharmaceuticals Inc

Gamma Pharmaceuticals Inc. ([ www.gammapharma.com ]) is a marketing and product formulation company selling its own branded products through wholesalers and direct to retailers, both in the US and internationally. Gamma's core focus is the marketing and sale of vitamins and nutriceuticals, OTC pharmaceutical products and personal care products in Greater China and the United States. Branded nutritional supplements are sold under the trademarks Brilliant Choice™ children's nutritional supplements featuring the call to action, "Mom, you've made a brilliant choice for you children's nutrition"; SAVVY™ adult nutritional supplements featuring the call to action, "Be SAVVY Stay Healthy"; and, Jugular Energy Products™ and high performance supplements featuring the call to action, "Go for the Jugular™." Gamma's customer focus is on selling products in the Lifestyle of Health & Sustainability ("LOHAS") marketplace and in the Energy Supplement Market. A series of innovative marketing programs supports Gamma's product sales and retail partners.

At present Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize proprietary "Gel Delivery Technology®," to create innovative gel product forms that give consumers a more pleasant experience. Gel Delivery Technology® characteristics include rapid absorption, convenience and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma has developed formulas and strategies for Metabolic Syndrome and Diabetes Type II, Stress Reduction, Cognition, Well being, Menopause Symptoms, and Personal Care Products. Gamma also develops and manufactures house brands for major retailers. At this time, Gamma has a total of 36 SKU's and holds licenses for 9 SKUs in China.

Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this Press Release regarding any impact the quotation of the Company's stock has on the Pink Sheets or the lack thereof on the OTCBB, and any other effects of the above are forward-looking statements. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

Contributing Sources